• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量分析方法验证的总误差法

A total error approach for the validation of quantitative analytical methods.

作者信息

Hoffman David, Kringle Robert

机构信息

Preclinical and Research Biostatistics, Sanofi-aventis, Bridgewater, New Jersey, USA.

出版信息

Pharm Res. 2007 Jun;24(6):1157-64. doi: 10.1007/s11095-007-9242-3. Epub 2007 Mar 21.

DOI:10.1007/s11095-007-9242-3
PMID:17373576
Abstract

PURPOSE

Typical acceptance criteria for analytical methods are not chosen with regard to the concept of method suitability and are commonly based on ad-hoc rules. Such approaches yield unknown and uncontrolled risks of accepting unsuitable analytical methods and rejecting suitable analytical methods. This paper proposes a formal statistical framework for the validation of analytical methods, which incorporates the use of total error and controls the risks of incorrect decision-making.

MATERIALS AND METHODS

A total error approach for method validation based on the use of two-sided beta-content tolerance intervals is proposed. The performance of the proposed approach is compared to the performance of current ad-hoc approaches via simulation techniques.

RESULTS

The current ad-hoc approaches for method validation fail to control the risk of incorrectly accepting unsuitable analytical methods. The proposed total error approach controls the risk of incorrectly accepting unsuitable analytical methods and provides adequate power to accept truly suitable methods.

CONCLUSION

Current ad-hoc approaches to method validation are inconsistent with ensuring method suitability. A total error approach based on the use of two-sided beta-content tolerance intervals was developed. The total error approach offers a formal statistical framework for assessing analytical method performance. The approach is consistent with the concept of method suitability and controls the risk of incorrectly accepting unsuitable analytical methods.

摘要

目的

分析方法的典型验收标准并非根据方法适用性概念来选择,通常基于临时规则。此类方法在接受不合适的分析方法以及拒绝合适的分析方法方面会产生未知且不受控制的风险。本文提出了一个用于分析方法验证的正式统计框架,该框架纳入了总误差的使用并控制错误决策的风险。

材料与方法

提出了一种基于双侧贝塔含量容忍区间使用的方法验证总误差方法。通过模拟技术将所提出方法的性能与当前临时方法的性能进行比较。

结果

当前用于方法验证的临时方法无法控制错误接受不合适分析方法的风险。所提出的总误差方法控制了错误接受不合适分析方法的风险,并为接受真正合适的方法提供了足够的效力。

结论

当前用于方法验证的临时方法与确保方法适用性不一致。开发了一种基于双侧贝塔含量容忍区间使用的总误差方法。总误差方法为评估分析方法性能提供了一个正式的统计框架。该方法与方法适用性概念一致,并控制了错误接受不合适分析方法的风险。

相似文献

1
A total error approach for the validation of quantitative analytical methods.定量分析方法验证的总误差法
Pharm Res. 2007 Jun;24(6):1157-64. doi: 10.1007/s11095-007-9242-3. Epub 2007 Mar 21.
2
A Generalized Pivotal Quantity Approach to Analytical Method Validation Based on Total Error.一种基于总误差的分析方法验证的广义枢轴量法。
PDA J Pharm Sci Technol. 2015 Nov-Dec;69(6):725-35. doi: 10.5731/pdajpst.2015.01081.
3
Uncertainty profiles for the validation of analytical methods.分析方法验证的不确定度概况。
Talanta. 2011 Sep 15;85(3):1535-42. doi: 10.1016/j.talanta.2011.06.042. Epub 2011 Jun 21.
4
Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--Part I.定量分析方法验证策略的协调统一。SFSTP提案——第一部分。
J Pharm Biomed Anal. 2004 Nov 15;36(3):579-86. doi: 10.1016/j.jpba.2004.07.027.
5
Flexibility and applicability of β-expectation tolerance interval approach to assess the fitness of purpose of pharmaceutical analytical methods.β-期望容限区间法评估药物分析方法适用性和适用性的灵活性。
Drug Test Anal. 2012 Dec;4(12):1014-27. doi: 10.1002/dta.1345. Epub 2012 May 21.
6
A risk-based analysis of the AAPS conference report on quantitative bioanalytical methods validation and implementation.基于风险的对美国药学科学家协会(AAPS)定量生物分析方法验证与实施会议报告的分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Aug 1;877(23):2235-43. doi: 10.1016/j.jchromb.2009.06.019. Epub 2009 Jun 18.
7
Reply to the responses on the comments on "Uncertainty profiles for the validation of analytical methods" by Saffaj and Ihssane.回复 Saffaj 和 Ihssane 在“分析方法验证的不确定性分析”评论中的回复。
Talanta. 2012 Oct 15;100:290-2. doi: 10.1016/j.talanta.2012.07.047. Epub 2012 Aug 2.
8
Statistical assessment of analytical method transfer.分析方法转移的统计评估
J Biopharm Stat. 2008;18(5):1005-12. doi: 10.1080/10543400802287347.
9
[Analytical validation in compendium methods].[药典方法中的分析验证]
Eisei Shikenjo Hokoku. 1993(111):141-2.
10
Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part II.定量分析方法验证策略的协调统一。法国毒理学会提议——第二部分。
J Pharm Biomed Anal. 2007 Sep 21;45(1):70-81. doi: 10.1016/j.jpba.2007.06.013. Epub 2007 Jun 16.

引用本文的文献

1
A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring.一种用于定量测定血浆中囊性纤维化药物(卡福托)的液相色谱 - 串联质谱法及其在治疗监测中的应用。
Molecules. 2025 Apr 22;30(9):1866. doi: 10.3390/molecules30091866.
2
Quality Control and Safety Assessment of Online-Purchased Food Supplements Containing Red Yeast Rice (RYR).网购含红曲米的食品补充剂的质量控制与安全性评估
Foods. 2024 Jun 18;13(12):1919. doi: 10.3390/foods13121919.
3
Establishment and Validation of Fourier Transform Infrared Spectroscopy (FT-MIR) Methodology for the Detection of Linoleic Acid in Buffalo Milk.

本文引用的文献

1
Bioanalytical method validation for macromolecules in support of pharmacokinetic studies.支持药代动力学研究的大分子生物分析方法验证。
Pharm Res. 2005 Sep;22(9):1425-31. doi: 10.1007/s11095-005-5917-9. Epub 2005 Aug 24.
2
Two-sided tolerance intervals for balanced and unbalanced random effects models.平衡和非平衡随机效应模型的双侧容忍区间。
J Biopharm Stat. 2005;15(2):283-93. doi: 10.1081/BIP-200048826.
3
Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--Part I.定量分析方法验证策略的协调统一。SFSTP提案——第一部分。
用于检测水牛奶中亚油酸的傅里叶变换红外光谱(FT-MIR)方法的建立与验证
Foods. 2023 Mar 12;12(6):1199. doi: 10.3390/foods12061199.
4
Quantitative tandem mass spectrometry in the clinical laboratory: Regulation and opportunity for validation of laboratory developed tests.临床实验室中的定量串联质谱分析:实验室自建检测方法验证的规范与机遇
J Mass Spectrom Adv Clin Lab. 2023 Mar 5;28:82-90. doi: 10.1016/j.jmsacl.2023.03.001. eCollection 2023 Apr.
5
Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.建立并验证了一种采用稳定同位素内标物的多重 UHPLC-MS/MS 分析方法,用于监测 HIV 感染者体内比克替拉韦、卡替拉韦、多拉韦林和利匹韦林这 4 种抗逆转录病毒药物的血浆浓度。
J Mass Spectrom. 2020 Jun;55(6):e4506. doi: 10.1002/jms.4506. Epub 2020 Mar 11.
6
Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma.开发和验证一种用于测定抗多耐药结核病的研究性抗生素马佐环素(PBTZ169)及其在人血浆中的五种活性代谢物的多重 UHPLC-MS/MS 方法。
PLoS One. 2019 May 31;14(5):e0217139. doi: 10.1371/journal.pone.0217139. eCollection 2019.
7
Reproducibility of antimicrobial test methods.抗菌测试方法的重现性。
Sci Rep. 2018 Aug 22;8(1):12531. doi: 10.1038/s41598-018-30282-3.
8
Statistical considerations for assessment of bioanalytical incurred sample reproducibility.生物分析中所测样本重现性评估的统计学考量
AAPS J. 2009 Sep;11(3):570-80. doi: 10.1208/s12248-009-9134-z. Epub 2009 Aug 8.
J Pharm Biomed Anal. 2004 Nov 15;36(3):579-86. doi: 10.1016/j.jpba.2004.07.027.
4
Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules.支持大分子药物动力学评估的配体结合分析生物分析方法验证的建议。
Pharm Res. 2003 Nov;20(11):1885-900. doi: 10.1023/b:pham.0000003390.51761.3d.
5
An analysis of the SFSTP guide on validation of chromatographic bioanalytical methods: progress and limitations.对色谱生物分析方法验证的SFSTP指南的分析:进展与局限
J Pharm Biomed Anal. 2003 Aug 8;32(4-5):753-65. doi: 10.1016/s0731-7085(03)00182-1.
6
Sample sizes for batch acceptance from single- and multistage designs using two-sided normal tolerance intervals with specified content.使用具有指定内容的双侧正态公差区间的单阶段和多阶段设计中批量验收的样本量。
J Biopharm Stat. 2001 Nov;11(4):335-46.
7
Workshop on bioanalytical methods validation for macromolecules: summary report.大分子生物分析方法验证研讨会:总结报告
Pharm Res. 2001 Sep;18(9):1373-83. doi: 10.1023/a:1013062600566.
8
Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective.生物分析免疫测定法的验证:制药行业视角
J Pharm Biomed Anal. 2000 Jan;21(6):1249-73. doi: 10.1016/s0731-7085(99)00244-7.
9
An assessment of the 4-6-20 rule for acceptance of analytical runs in bioavailability, bioequivalence, and pharmacokinetic studies.生物利用度、生物等效性和药代动力学研究中分析批次验收的4-6-20规则评估。
Pharm Res. 1994 Apr;11(4):556-60. doi: 10.1023/a:1018922701174.